This page shows the latest heart failure news and features for those working in and with pharma, biotech and healthcare.
Hypertrophic cardiomyopathy (HCM) is a chronic and progressive disease which causes excessive contraction of the heart muscles and reduces the ability of the left ventricle to fill. ... In both obstructive or non-obstructive HCM patients, physical
That growth was led by an increase in revenue for AZ’s heart failure treatment Farxiga (dapagliflozin), which saw a 27% increase in 2020 to $1.96bn.
added. In the Q4 results, Novartis highlighted its main growth drivers – including its heart failure drug Entresto (sacubitril/valsartan), its immunology therapy Cosentyx (secukinumab) and its spinal muscular atrophy (SMA) gene
heart failure.
In October, AZ also divested the commercial rights to its heart failure and hypertension treatments Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in
Novartis’ main growth drivers, and protectors against the continuing impact caused by the COVID-19 pandemic, includes its spinal muscular atrophy (SMA) gene therapy Zolgensma and chronic heart failure med Entresto
More from news
Approximately 46 fully matching, plus 254 partially matching documents found.
patients are at risk of heart failure or stroke.
The typical drug discovery process takes about a decade, costs $2bn and suffers a 90% failure rate during clinical development. ... The project is initially connecting four of London’s premier teaching hospitals, offering AI services to accelerate work
heart failure also have CKD.
Hudson had a distinguished career at Novartis, presiding over the launches and roll-outs of psoriasis blockbuster Cosentyx (secukinumab), spinal muscular atrophy gene therapy Zolgensma (onasemnogene abeparvovec) and heart failure therapy
Diabetes therapy Farxiga (dapagliflozin) has the potential to go where no other drug in the SGLT2 inhibitor class has gone before as it secures approval for heart failure in both diabetic
More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.
for congestive heart failure and Huntington's disease into the clinic.”.
Sherman has over 30 years' cardiology experience, with a focus on cell-based therapies for treating patients post-myocardial infarction and with heart failure.
pain and heart failure. .
Dr Foo was responsible for the establishment and execution of multiple programmes in heart failure and the cardiorenal space at Novartis and will use her experience to lead research at ... Her unique combination of both early- and late-stage
Prior to this period at Affymax, Dr Polu was executive director, global development at Amgen, where he worked in the development of products in nephrology, diabetes and heart failure.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
technology, AI, and deep-learning-enabled diagnostics for remote monitoring of congestive heart failure, chronic diseases, and COVID-19.
For example, if those with advanced heart failure were unable to participate, would it be the same for those with a milder condition? ... Is it necessary to exclude all people with varying degrees of heart failure?
Introduction. Cardiovascular disease (CVD), which covers a wide range of conditions, such as coronary heart disease, heart valve disease (HVD) and strokes, is responsible for a quarter of all deaths in ... Integrated care organisations. Many CVD
From 2020/21, PCNs will use digital health records and health management tools to identify moderate frailty and detect and intervene to treat undiagnosed disorders, such as heart failure.
ECHO delivers dedicated medical communications specialising in the areas of endocrinology, cardiovascular disease, heart failure and obesity.
More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.
No results were found
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...